We are live on
!
Find out more
EEG
E.E. Geduld Portfolio holdings
AUM
$178M
1-Year Est. Return
29.34%
This Fund
S&P 500
This Quarter
Est. Return
+7.42%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$207M
AUM Growth
+$43.3M
(+26%)
Cap. Flow
+$4.36M
Cap. Flow
% of AUM
2.1%
Top 10 Holdings %
Top 10 Hldgs %
41.81%
Holding
434
New
117
Increased
50
Reduced
37
Closed
98
Avg Time Held Equity + Options
1.2
quarters
Top 10 Avg Time Held Equity + Options
0.5
quarters
Top 20 Avg Time Held Equity + Options
0.9
quarters
Avg Time Held Equity only
1.2
quarters
Top 10 Avg Time Held Equity only
0.9
quarters
Top 20 Avg Time Held Equity only
1.1
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
+$4.51M |
| 2 |
3D Systems Corp
DDD
|
+$1.4M |
| 3 |
Ciena
CIEN
|
+$953K |
| 4 |
Vince Holding Corp
VNCE
|
+$906K |
| 5 |
Lennar Class A
LEN
|
+$886K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.37M |
| 2 |
Infoblox Inc
BLOX
|
+$1.46M |
| 3 |
Guidewire Software
GWRE
|
+$942K |
| 4 |
Puma Biotechnology
PBYI
|
+$880K |
| 5 |
QLIK
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
|
+$856K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.04% |
| 2 | Financials | 25.83% |
| 3 | Healthcare | 10.16% |
| 4 | Consumer Discretionary | 6.24% |
| 5 | Technology | 5.57% |
Similar funds
BC
PFM
SRP
CF
SA
WSA
SIG
VWM
E.E. Geduld's Q4 2013 Portfolio in Review
As of Q4 2013, E.E. Geduld held 434 positions worth $207M, up 26% from $164M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
E.E. Geduld's Q4 2013 filing shows 117 new, 50 increased, 37 reduced and 98 closed positions. Its largest new stake was Ariad Pharmaceuticals Inc: 835,100 shares worth $5.7M. The largest sale was PHARMACYCLICS INC, an estimated $2.37M.
By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, up from 34% a quarter earlier, followed by Financials and Healthcare.
- E.E. Geduld's largest Q4 2013 buy was Ariad Pharmaceuticals Inc: 835,100 shares worth $5.7M.
- E.E. Geduld added most to Hess in Q4 2013, an estimated $812K increase.
- E.E. Geduld's biggest Q4 2013 reduction was PHARMACYCLICS INC, cutting an estimated $2.37M.
- E.E. Geduld fully exited Infoblox Inc in Q4 2013, selling an estimated $1.46M.
- E.E. Geduld's ten largest holdings make up 42% of its $207M portfolio in Q4 2013.
- E.E. Geduld opened 117 new positions and closed 98 in Q4 2013.
- E.E. Geduld's portfolio value rose 26% quarter-over-quarter to $207M.
Based on E.E. Geduld's 13F filing for Q4 2013, filed 23 Jan 2014.